Communiqués Palatin Technologies, Inc.

Actions

Marché Fermé - London S.E. 16:06:10 22/05/2026			Après clôture 21:04:12
15,01 ^USD	-28,52%		24,57	+63,69%

29/06	Les plus fortes hausses en avant-Bourse	MT
18/05	Palatin Technologies transfère sa cotation sur le Nasdaq	MT

06/08	StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It	NE
23/09/25	Palatin Earns EUR5.5 Million Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim	AQ
19/08/25	Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with Retinal diseases	AQ
16/07/25	Palatin's Oral Obesity Drug Shows Remarkable Results: The Hidden Gem in the Weight Loss Race	AQ